Abstract
Nineteen cases were reinvestigated 8-14 years after treatment with SK or heparin. Judging from personal interviews, foot volumometry and phlebography, treatment with SK appears to be more preferable since it was less often followed by late severe postthrombotic changes.
Publication types
-
Clinical Trial
-
Comparative Study
-
Randomized Controlled Trial
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Drug Evaluation
-
Follow-Up Studies
-
Heparin / therapeutic use*
-
Humans
-
Middle Aged
-
Streptokinase / therapeutic use*
-
Thrombophlebitis / drug therapy*
-
Time Factors